October 6. The World Health Organization (WHO) has recommended the widespread use of a malaria vaccine among children in Africa and other areas of high malaria transmission – a breakthrough in the long fight against the deadly disease.
The road to an effective malaria vaccine has been long, with many vaccines showing only modest efficacy, Live Science previously reported.
The vaccine WHO has endorsed – called RTS, S, or Mosquirix – is more than 30 years in the making and works to prime the immune system against Plasmodium falciparum – the deadliest malaria parasite and the most common one in Africa.
It is the first vaccine to complete large-scale clinical trials and show that it can significantly reduce malaria, including life-threatening malaria, in young children in Africa, according to the WHO.
One modeling study, published in November 2020 in the journal PLOS Medicine, found that the vaccine could prevent 5.3 million cases and 24,000 deaths among children 5 years and younger every year.
Source: Science Alert